EGFR and non-small cell lung carcinoma: Our findings demonstrate that the combination of EGFR-TKI and whole brain radiotherapy results in a longer OS than whole brain radiotherapy alone in NSCLC patients with brain metastasis, and brain metastasis is a prognostic factor for advanced NSCLC patients harboring EGFR mutation, which may be attributable to a higher risk of death.